HOME >> MEDICINE >> NEWS
NIAID DNA vaccine for H5N1 avian influenza enters human trial

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.

Unlike conventional flu vaccines, which are developed by growing the influenza virus in hens' eggs and then administered as a weakened or killed form of the virus, DNA-based vaccines contain only portions of the influenza virus' genetic material. Once inside the body, the DNA instructs human cells to make proteins that act as a vaccine against the virus.

VRC Director Gary Nabel, M.D., Ph.D., together with a team of scientists from the VRC recognized the potential for employing new vaccine technology against influenza, a disease for which effective vaccines have long been made, but for which the reliability of supply and manufacturing capacity has been problematic. Dr. Nabel and his colleagues previously have shown the DNA vaccine approach to be effective against influenza viruses in animal models, including highly pathogenic viruses such as the H5N1 strain and the H1N1 virus that caused the deadly 1918 pandemic. The DNA vaccine used in this study is similar to other investigational vaccines evaluated by the VRC that hold promise for controlling other viruses, such as HIV, Ebola, SARS and West Nile.

"An effective H5N1 influenza vaccine would provide a potentially life-saving advance against a global health threat," notes NIAID Director Anthony S. Fauci, M.D. "More broadly, development of this DNA vaccine technology has the potential to improve our production capacity for vaccines to prevent seasonal influenza and other diseases."

"
'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Jan-2007


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID media availability: Examining genetic variability of malaria parasite offers insight
3. NIAID awards $4 million to develop anti-radiation treatments
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... ... provider of advanced delivery technologies and development solutions for drugs, biologics and ... Biologics, will present at the annual US Bioassay Conference of the BioPharmaceutical ...
(Date:2/19/2019)... ... February 19, 2019 , ... Tap water issues in ... The Villages FL proudly serving over 3,500 satisfied customers. I’m looking forward to ... Jacksonville area selling and installing our popular Water Filtration Systems," says Bob Novak, ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... with Clover Creek Cultivation LLC , a newly-licensed cannabis cultivation and manufacturing ... hydrocarbon and ethanol extraction, distillation, and ISO-7 product formulation, while Clover Creek is ...
(Date:2/19/2019)... ... February 19, 2019 , ... The California Dental Association is ... loan refinancing as a new member benefit. , Student loan debt is ... debt for all indebted graduates in the class of 2018 for public and ...
(Date:2/19/2019)... ... 2019 , ... ClearHealth Quality Institute (CHQI) has identified Emily ... Recognized Consultants. The CHQI Recognized Consultant Program trains third-parties to assist organizations, such ... Ms. Wein and Mr. Einhorn are part of Foley’s Telemedicine & Digital Health ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... ... wellness industry. The rapid growth of this sector is expected to reach $11.6 ... one of the major leaders in this space. The company makes best in ...
(Date:2/19/2019)... ... 18, 2019 , ... Shady Grove Fertility invites information seekers ... egg freezing, and much more to attend the second annual Canadian Fertility Show, ... Joseph Doyle, M.D. on February 23, 2019 from 9:30 AM to 5 ...
(Date:2/16/2019)... ... February 15, 2019 , ... ... Recognition Program (MNSHARP) award for safety excellence. Commissioner Kristin Batson, Department of Labor ... award. , Safety is more than just a set of rules for AP; ...
Breaking Medicine Technology:
Cached News: